Ambu A/S (AMBBY) versus Its Competitors Critical Analysis

Ambu A/S (OTCMKTS:AMBBY) is one of 665 public companies in the “Holding & other investment offices” industry, but how does it compare to its peers? We will compare Ambu A/S to similar businesses based on the strength of its analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends.

Institutional and Insider Ownership

54.3% of shares of all “Holding & other investment offices” companies are owned by institutional investors. 25.6% of shares of all “Holding & other investment offices” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Ambu A/S and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ambu A/S	7.23%	6.80%	5.32%
Ambu A/S Competitors	-24.81%	-46.30%	-1.24%

Earnings and Valuation

This table compares Ambu A/S and its peers gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Ambu A/S	$684.73 million	$24.09 million	95.85
Ambu A/S Competitors	$1.13 billion	$84.16 million	48.77

Ambu A/S’s peers have higher revenue and earnings than Ambu A/S. Ambu A/S is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Analyst Ratings

This is a summary of recent ratings for Ambu A/S and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ambu A/S	0	0	1	0	3.00
Ambu A/S Competitors	126	559	858	14	2.49

As a group, “Holding & other investment offices” companies have a potential upside of 72.33%. Given Ambu A/S’s peers higher probable upside, analysts plainly believe Ambu A/S has less favorable growth aspects than its peers.

Ambu A/S Company Profile

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.